Study of A3309 in Patients With Dyslipidemia

Status:
Completed

Trial end date:
2010-09-01

Target enrollment:

Participant gender:

The purpose of this trial is to determine the efficacy and safety of A3309 administered to patients with dyslipidemia (high cholesterol levels).

Phase 2

Albireo